A citation-based method for searching scientific literature

Yinnan Chen, Yanmin Zhang. Pharmacol Ther 2016
Times Cited: 13







List of co-cited articles
84 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells.
Syed M Meeran, Shweta N Patel, Tak-Hang Chan, Trygve O Tollefsbol. Cancer Prev Res (Phila) 2011
78
30

Telomerase as a Cancer Target. Development of New Molecules.
D L Mengual Gomez, R G Armando, C S Cerrudo, P D Ghiringhelli, D E Gomez. Curr Top Med Chem 2016
40
30

EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Anshu Mittal, Mitchell S Pate, Rebecca C Wylie, Trygve O Tollefsbol, Santosh K Katiyar. Int J Oncol 2004
111
23

Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells.
Sutapa Chakraborty, Utpal Ghosh, N P Bhattacharyya, R K Bhattacharya, Madhumita Roy. Mutat Res 2006
73
23

Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.
Joel B Berletch, Canhui Liu, William K Love, Lucy G Andrews, Santosh K Katiyar, Trygve O Tollefsbol. J Cell Biochem 2008
136
23



Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria.
Nilesh K Sharma, Aurelio Reyes, Paula Green, Matthieu J Caron, Marcelo G Bonini, Donna M Gordon, Ian J Holt, Janine Hertzog Santos. Nucleic Acids Res 2012
100
23

Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line.
Cheppail Ramachandran, Hugo B Fonseca, Perseus Jhabvala, Enrique A Escalon, Steven J Melnick. Cancer Lett 2002
100
23

Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms.
Yuanyuan Li, Liang Liu, Lucy G Andrews, Trygve O Tollefsbol. Int J Cancer 2009
115
23

Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity.
Sutapa Mukherjee Nee Chakraborty, Utpal Ghosh, N P Bhattacharyya, R K Bhattacharya, Subhabrata Dey, Madhumita Roy. Mol Cell Biochem 2007
48
23

Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.
Karima Ait-Aissa, Johnathan D Ebben, Andrew O Kadlec, Andreas M Beyer. Pharmacol Res 2016
21
23

Role of telomeres and telomerase in cancer.
Jerry W Shay, Woodring E Wright. Semin Cancer Biol 2011
295
23

Therapeutic Targeting of Telomerase.
Kathrin Jäger, Michael Walter. Genes (Basel) 2016
61
23

Treating Cancer by Targeting Telomeres and Telomerase.
Marko Ivancich, Zachary Schrank, Luke Wojdyla, Brandon Leviskas, Adijan Kuckovic, Ankita Sanjali, Neelu Puri. Antioxidants (Basel) 2017
48
23

Vaccination of patients with cutaneous melanoma with telomerase-specific peptides.
Robert E Hunger, Kristin Kernland Lang, Carrie J Markowski, Sissel Trachsel, Mona Møller, Jon A Eriksen, Anne-Marie Rasmussen, Lasse R Braathen, Gustav Gaudernack. Cancer Immunol Immunother 2011
31
15


Telomerase and cancer therapeutics.
Calvin B Harley. Nat Rev Cancer 2008
467
15



Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer.
Paal F Brunsvig, Steinar Aamdal, Marianne K Gjertsen, Gunnar Kvalheim, Carrie J Markowski-Grimsrud, Ingunn Sve, Marianne Dyrhaug, Sissel Trachsel, Mona Møller, Jon A Eriksen,[...]. Cancer Immunol Immunother 2006
161
15

Gefitinib induces apoptosis and decreases telomerase activity in MDA-MB-231 human breast cancer cells.
Dong-Oh Moon, Mun-Ock Kim, Moon-Soo Heo, Jae-Dong Lee, Yung Hyun Choi, Gi-Young Kim. Arch Pharm Res 2009
21
15

Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients.
Caroline Staff, Fariba Mozaffari, Jan-Erik Frödin, Håkan Mellstedt, Maria Liljefors. Int J Oncol 2014
35
15

A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.
Daniela Fenoglio, Paolo Traverso, Alessia Parodi, Laura Tomasello, Simone Negrini, Francesca Kalli, Florinda Battaglia, Francesca Ferrera, Stefania Sciallero, Giuseppe Murdaca,[...]. Cancer Immunol Immunother 2013
38
15



Pharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.
Yuebo Gan, Jie Lu, Bertrand Z Yeung, Christopher T Cottage, M Guillaume Wientjes, Jessie L-S Au. AAPS J 2015
9
22


Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study.
A Kotsakis, E-K Vetsika, S Christou, D Hatzidaki, N Vardakis, D Aggouraki, G Konsolakis, V Georgoulias, Ch Christophyllakis, P Cordopatis,[...]. Ann Oncol 2012
34
15

Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients.
Jon Amund Kyte, Gustav Gaudernack, Svein Dueland, Sissel Trachsel, Lars Julsrud, Steinar Aamdal. Clin Cancer Res 2011
73
15

Telomeres and telomerase in cancer.
Steven E Artandi, Ronald A DePinho. Carcinogenesis 2010
488
15


A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors.
John Nemunaitis, Alex W Tong, Michael Nemunaitis, Neil Senzer, Anagha P Phadke, Cynthia Bedell, Ned Adams, Yu-An Zhang, Phillip B Maples, Salina Chen,[...]. Mol Ther 2010
162
15


Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.
Gary Middleton, Paul Silcocks, Trevor Cox, Juan Valle, Jonathan Wadsley, David Propper, Fareeda Coxon, Paul Ross, Srinivasan Madhusudan, Tom Roques,[...]. Lancet Oncol 2014
178
15

A novel telomerase template antagonist (GRN163) as a potential anticancer agent.
Akira Asai, Yuko Oshima, Yoshihiro Yamamoto, Taka-aki Uochi, Hideaki Kusaka, Shiro Akinaga, Yoshinori Yamashita, Krisztina Pongracz, Ronald Pruzan, Ellen Wunder,[...]. Cancer Res 2003
151
15

Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.
Jian Hu, Soyoon Sarah Hwang, Marc Liesa, Boyi Gan, Ergun Sahin, Mariela Jaskelioff, Zhihu Ding, Haoqiang Ying, Adam T Boutin, Hailei Zhang,[...]. Cell 2012
180
15


Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice.
S E Artandi, S Chang, S L Lee, S Alson, G J Gottlieb, L Chin, R A DePinho. Nature 2000
834
15

Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.
Robert H Vonderheide, Susan M Domchek, Joachim L Schultze, Daniel J George, Kara M Hoar, Dih-Yih Chen, Katherine F Stephans, Kenkichi Masutomi, Massimo Loda, Zhinan Xia,[...]. Clin Cancer Res 2004
191
15

Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer.
Zhen Su, Jens Dannull, Benjamin K Yang, Philipp Dahm, Doris Coleman, Donna Yancey, Sylvia Sichi, Donna Niedzwiecki, David Boczkowski, Eli Gilboa,[...]. J Immunol 2005
250
15

Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide.
Irini Bolonaki, Athanassios Kotsakis, Elsa Papadimitraki, Despoina Aggouraki, George Konsolakis, Aphrodite Vagia, Charalambos Christophylakis, Irini Nikoloudi, Elefterios Magganas, Athanassios Galanis,[...]. J Clin Oncol 2007
81
15

Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
15


Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.
Wen Xue, Lars Zender, Cornelius Miething, Ross A Dickins, Eva Hernando, Valery Krizhanovsky, Carlos Cordon-Cardo, Scott W Lowe. Nature 2007
15

Vorinostat, SAHA, represses telomerase activity via epigenetic regulation of telomerase reverse transcriptase in non-small cell lung cancer cells.
Chien-Te Li, Yi-Min Hsiao, Tzu-Chin Wu, Yu-Wen Lin, Kun-Tu Yeh, Jiunn-Liang Ko. J Cell Biochem 2011
29
15

N-acetyl cysteine mitigates curcumin-mediated telomerase inhibition through rescuing of Sp1 reduction in A549 cells.
I-Lun Hsin, Gwo-Tarng Sheu, Hung-Hsuan Chen, Ling-Yen Chiu, Horng-Dar Wang, Hsiu-Wen Chan, Chung-Ping Hsu, Jiunn-Liang Ko. Mutat Res 2010
39
15

Sulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathway.
Dong-Oh Moon, Sang-Hyuck Kang, Ki-Cheon Kim, Mun-Ock Kim, Yung Hyun Choi, Gi-Young Kim. Cancer Lett 2010
41
15

Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells.
Katrin Hoffmeyer, Angelo Raggioli, Stefan Rudloff, Roman Anton, Andreas Hierholzer, Ignacio Del Valle, Kerstin Hein, Riana Vogt, Rolf Kemler. Science 2012
344
15

Extension of life-span by introduction of telomerase into normal human cells.
A G Bodnar, M Ouellette, M Frolkis, S E Holt, C P Chiu, G B Morin, C B Harley, J W Shay, S Lichtsteiner, W E Wright. Science 1998
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.